๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Maternal serum human chorionic gonadotrophin levels in systemic lupus erythematosus and antiphospholipid syndrome

โœ Scribed by Ron Maymon; Howard Cuckle; Indera K. Sehmi; Arie Herman; Dan Sherman


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
49 KB
Volume
21
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

โœฆ Synopsis


Maternal serum human chorionic gonadotrophin (hCG) levels were measured during the second and the third trimesters of pregnancy in patients with either systemic lupus erythematosus (SLE) or primary antiphospholipid syndrome (APS). All results were expressed in multiples of the gestation-speciยฎc normal medians (MoM). The median MoM level in 17 samples from SLE patients was 1.48 compared with 0.79 MoM in 99 controls of similar gestation ( p<0.002, Wilcoxon Rank sum test). In contrast the median MoM level in 19 samples from primary APS patients was only 1.14. These preliminary ยฎndings should be further studied to evaluate the implications for Down syndrome screening, detection of SLE cases during pregnancy and the prediction of adverse outcome in SLE gestations.


๐Ÿ“œ SIMILAR VOLUMES


Serum inhibin A levels in pregnant women
โœ Ron Maymon; Indera K. Sehmi; Arie Herman; Richard G. Jones; Dan Sherman; Howard ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 2 views

Maternal serum inhibin A levels are increased on average in pregnancies affected by Down syndrome (DS). However, some reports have found increased serum levels in women with pre-eclamptic toxaemia as well. In the current study, maternal serum inhibin A was retrospectively measured in a series of 32

Second-trimester maternal serum alpha-fe
โœ Yung Hang Lam; Arabinda Ghosh; Mary Hoi Yin Tang; Lawrence Chang Hung Tang; Chin ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB ๐Ÿ‘ 2 views

Second-trimester maternal serum screening for fetal Down's syndrome is well established in many Western countries. Its usefulness and acceptability is unknown in the Asian countries. Between June 1994 and December 1996, we offered second-trimester serum AFP and hCG screening to pregnant women in Hon